Goldman Sachs’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Sell |
11,585
-27,462
| -70% | -$414K | ﹤0.01% | 4764 |
|
|
2025
Q1 | $628K | Sell |
39,047
-11,208
| -22% | -$180K | ﹤0.01% | 4127 |
|
|
2024
Q4 | $875K | Buy |
50,255
+14,560
| +41% | +$253K | ﹤0.01% | 3991 |
|
|
2024
Q3 | $626K | Buy |
+35,695
| New | +$626K | ﹤0.01% | 4002 |
|
|
2024
Q2 | – | Sell |
-12,206
| Closed | -$106K | – | 4872 |
|
|
2024
Q1 | $106K | Buy |
+12,206
| New | +$106K | ﹤0.01% | 4455 |
|
|
2023
Q3 | – | Sell |
-10,279
| Closed | -$73.9K | – | 4891 |
|
|
2023
Q2 | $73.9K | Buy |
+10,279
| New | +$73.9K | ﹤0.01% | 4616 |
|
|
2022
Q3 | – | Sell |
-12,173
| Closed | -$19K | – | 5617 |
|
|
2022
Q2 | $19K | Sell |
12,173
-3,622
| -23% | -$5.65K | ﹤0.01% | 5433 |
|
|
2022
Q1 | $77K | Buy |
15,795
+3,273
| +26% | +$16K | ﹤0.01% | 5381 |
|
|
2021
Q4 | $185K | Buy |
12,522
+66
| +0.5% | +$975 | ﹤0.01% | 5027 |
|
|
2021
Q3 | $269K | Buy |
12,456
+1,244
| +11% | +$26.9K | ﹤0.01% | 4722 |
|
|
2021
Q2 | $184K | Sell |
11,212
-10,409
| -48% | -$171K | ﹤0.01% | 4942 |
|
|
2021
Q1 | $512K | Buy |
21,621
+12,664
| +141% | +$300K | ﹤0.01% | 4339 |
|
|
2020
Q4 | $214K | Buy |
+8,957
| New | +$214K | ﹤0.01% | 4240 |
|
|
2017
Q4 | – | Sell |
-20,761
| Closed | -$386K | – | 4263 |
|
|
2017
Q3 | $386K | Buy |
20,761
+2,646
| +15% | +$49.2K | ﹤0.01% | 3623 |
|
|
2017
Q2 | $626K | Sell |
18,115
-4,868
| -21% | -$168K | ﹤0.01% | 3403 |
|
|
2017
Q1 | $469K | Sell |
22,983
-19,898
| -46% | -$406K | ﹤0.01% | 3546 |
|
|
2016
Q4 | $279K | Sell |
42,881
-9,187
| -18% | -$59.8K | ﹤0.01% | 3750 |
|
|
2016
Q3 | $328K | Buy |
52,068
+27,068
| +108% | +$171K | ﹤0.01% | 3661 |
|
|
2016
Q2 | $112K | Buy |
+25,000
| New | +$112K | ﹤0.01% | 4084 |
|